130 related articles for article (PubMed ID: 33032188)
21. Indole and benzimidazole derivatives as steroid 5alpha-reductase inhibitors in the rat prostate.
Takami H; Kishibayashi N; Ishii A; Kumazawa T
Bioorg Med Chem; 1998 Dec; 6(12):2441-8. PubMed ID: 9925300
[TBL] [Abstract][Full Text] [Related]
22. Synthetic strategies, SAR studies, and computer modeling of indole 2 and 3-carboxamides as the strong enzyme inhibitors: a review.
Chehardoli G; Bahmani A
Mol Divers; 2021 Feb; 25(1):535-550. PubMed ID: 32394235
[TBL] [Abstract][Full Text] [Related]
23. Discovery of di-indolinone as a novel scaffold for protein tyrosine phosphatase 1B inhibitors.
Dai HL; Gao LX; Yang Y; Li JY; Cheng JG; Li J; Wen R; Peng YQ; Zheng JB
Bioorg Med Chem Lett; 2012 Dec; 22(24):7440-3. PubMed ID: 23122522
[TBL] [Abstract][Full Text] [Related]
24. Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities.
Chao SW; Chen LC; Yu CC; Liu CY; Lin TE; Guh JH; Wang CY; Chen CY; Hsu KC; Huang WJ
Eur J Med Chem; 2018 Jan; 143():792-805. PubMed ID: 29223096
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and promising anti-tumor efficacy of novel imidazo[1,2-a]pyridine derivatives as potent autotaxin allosteric inhibitors.
Lei H; Wang X; Zhao G; Li T; Cui Y; Wu H; Yang J; Jiang N; Zhai X
Eur J Med Chem; 2022 Jun; 236():114307. PubMed ID: 35436669
[TBL] [Abstract][Full Text] [Related]
26. Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition.
Ragle LE; Palanisamy DJ; Joe MJ; Stein RS; Norman DD; Tigyi G; Baker DL; Parrill AL
Bioorg Med Chem; 2016 Oct; 24(19):4660-4674. PubMed ID: 27544588
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors.
Song JU; Choi SP; Kim TH; Jung CK; Lee JY; Jung SH; Kim GT
Bioorg Med Chem Lett; 2015 Mar; 25(6):1254-8. PubMed ID: 25704891
[TBL] [Abstract][Full Text] [Related]
28. 1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors.
Renton P; Speed J; Maddaford S; Annedi SC; Ramnauth J; Rakhit S; Andrews J
Bioorg Med Chem Lett; 2011 Sep; 21(18):5301-4. PubMed ID: 21813276
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluations of oleanolic acid indole derivatives as hyaluronidase inhibitors with enhanced skin permeability.
He H; Li H; Akanji T; Niu S; Luo Z; Li D; Seeram NP; Wu P; Ma H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1665-1678. PubMed ID: 34309457
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of indole based acetohydrazide analogs: Their in vitro and in silico thymidine phosphorylase studies.
Taha M; Aldhamin EAJ; Almandil NB; Anouar EH; Uddin N; Alomari M; Rahim F; Adalat B; Ibrahim M; Nawaz F; Iqbal N; Alghanem B; Altolayyan A; Khan KM
Bioorg Chem; 2020 May; 98():103745. PubMed ID: 32200327
[TBL] [Abstract][Full Text] [Related]
31. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors.
Vrontaki E; Melagraki G; Kaffe E; Mavromoustakos T; Kokotos G; Aidinis V; Afantitis A
Curr Med Chem; 2016; 23(17):1708-24. PubMed ID: 26997151
[TBL] [Abstract][Full Text] [Related]
32. Discovery and synthesis of novel indole derivatives-containing 3-methylenedihydrofuran-2(3H)-one as irreversible LSD1 inhibitors.
Liu HM; Suo FZ; Li XB; You YH; Lv CT; Zheng CX; Zhang GC; Liu YJ; Kang WT; Zheng YC; Xu HW
Eur J Med Chem; 2019 Aug; 175():357-372. PubMed ID: 31096156
[TBL] [Abstract][Full Text] [Related]
33. Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors.
Magkrioti C; Kaffe E; Stylianaki EA; Sidahmet C; Melagraki G; Afantitis A; Matralis AN; Aidinis V
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977539
[TBL] [Abstract][Full Text] [Related]
34. Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.
Joncour A; Desroy N; Housseman C; Bock X; Bienvenu N; Cherel L; Labeguere V; Peixoto C; Annoot D; Lepissier L; Heiermann J; Hengeveld WJ; Pilzak G; Monjardet A; Wakselman E; Roncoroni V; Le Tallec S; Galien R; David C; Vandervoort N; Christophe T; Conrath K; Jans M; Wohlkonig A; Soror S; Steyaert J; Touitou R; Fleury D; Vercheval L; Mollat P; Triballeau N; van der Aar E; Brys R; Heckmann B
J Med Chem; 2017 Sep; 60(17):7371-7392. PubMed ID: 28731719
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel oxindole derivatives as potent α-glucosidase inhibitors.
Khan M; Yousaf M; Wadood A; Junaid M; Ashraf M; Alam U; Ali M; Arshad M; Hussain Z; Khan KM
Bioorg Med Chem; 2014 Jul; 22(13):3441-8. PubMed ID: 24825482
[TBL] [Abstract][Full Text] [Related]
36. Structure-Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode.
Miller LM; Keune WJ; Castagna D; Young LC; Duffy EL; Potjewyd F; Salgado-Polo F; Engel García P; Semaan D; Pritchard JM; Perrakis A; Macdonald SJ; Jamieson C; Watson AJ
J Med Chem; 2017 Jan; 60(2):722-748. PubMed ID: 27982588
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro evaluation of 3-(1-azolylmethyl)-1H-indoles and 3-(1-azolyl-1-phenylmethyl)-1H-indoles as inhibitors of P450 arom.
Le Borgne M; Marchand P; Duflos M; Delevoye-Seiller B; Piessard-Robert S; Le Baut G; Hartmann RW; Palzer M
Arch Pharm (Weinheim); 1997 May; 330(5):141-5. PubMed ID: 9237426
[TBL] [Abstract][Full Text] [Related]
38. Catalytic asymmetric synthesis of indole derivatives as novel α-glucosidase inhibitors in vitro.
Islam MS; Barakat A; Al-Majid AM; Ali M; Yousuf S; Iqbal Choudhary M; Khalil R; Ul-Haq Z
Bioorg Chem; 2018 Sep; 79():350-354. PubMed ID: 29807208
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel mono and bis-indole conduritol derivatives and their α/β-glycosidase inhibitory effects.
Çavdar H; Talaz O; Ekinci D
Bioorg Med Chem Lett; 2012 Dec; 22(24):7499-503. PubMed ID: 23137433
[TBL] [Abstract][Full Text] [Related]
40. Searching for indole derivatives as potential mushroom tyrosinase inhibitors.
Ferro S; Certo G; De Luca L; Germanò MP; Rapisarda A; Gitto R
J Enzyme Inhib Med Chem; 2016; 31(3):398-403. PubMed ID: 25826148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
